Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel pyrimidopyrimidinone derivative JND-3229 inhibits EGFR C797S mutant

Dec. 13, 2018

ABHD12 regulates immunostimulatory lipid pathways in vivo

Dec. 13, 2018

Kiniksa presents interim phase II data for rilonacept and initiates phase III RHAPSODY study

Dec. 13, 2018

Inflammasome inhibition is promising antibacterial therapy

Dec. 13, 2018

MTH1 expression levels predict breast cancer prognosis

Dec. 13, 2018

"Noncoding" regions produce tumor antigens

Dec. 13, 2018

Tumor T cells mostly just rubbernecking

Dec. 13, 2018

FDA accepts IND for Sermonix's phase II trial of oral lasofoxifene in breast cancer

Dec. 12, 2018

Aeglea announces phase III plans for pegzilarginase in arginase 1 deficiency

Dec. 12, 2018

Vect-Horus enters research collaboration agreement with Janssen

Dec. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...